Variant report
Variant | nsv548729 |
---|---|
Chromosome Location | chr1:195852133-195866450 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:17)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:17 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:195859567..195862131-chr1:195863598..195866284,2 | K562 | blood: | |
2 | chr1:195854670..195856185-chr1:195857598..195860308,2 | K562 | blood: | |
3 | chr1:195854670..195856185-chr1:195857598..195860308,2 | K562 | blood: | |
4 | chr1:195859567..195862131-chr1:195863598..195866284,2 | K562 | blood: | |
5 | chr1:195832078..195834352-chr1:195866206..195869346,3 | K562 | blood: | |
6 | chr1:195831209..195836948-chr1:195865315..195869441,6 | K562 | blood: | |
7 | chr1:195837170..195839918-chr1:195861015..195863064,2 | K562 | blood: | |
8 | chr1:195845594..195848428-chr1:195851192..195853399,2 | K562 | blood: | |
9 | chr1:195845835..195848707-chr1:195860208..195862083,2 | K562 | blood: | |
10 | chr1:195862339..195864260-chr1:195865555..195867697,3 | K562 | blood: | |
11 | chr1:195851101..195853777-chr1:195856895..195858997,3 | K562 | blood: | |
12 | chr1:195851101..195853777-chr1:195856895..195858997,3 | K562 | blood: | |
13 | chr1:195857673..195860102-chr1:195861318..195863869,3 | K562 | blood: | |
14 | chr1:195862339..195864260-chr1:195865555..195867697,3 | K562 | blood: | |
15 | chr1:195845835..195848328-chr1:195860583..195862092,2 | K562 | blood: | |
16 | chr1:195857673..195860102-chr1:195861318..195863869,3 | K562 | blood: | |
17 | chr1:195834331..195836964-chr1:195857452..195860455,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565250818 | chr1:195855413-195855414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532412933 | chr1:195855455-195855456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34922680 | chr1:195855463-195855464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188851276 | chr1:195855471-195855472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547866802 | chr1:195855480-195855481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561615760 | chr1:195855515-195855516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs373265469 | chr1:195855520-195855521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549223873 | chr1:195855528-195855529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529271953 | chr1:195855536-195855537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563435997 | chr1:195855538-195855539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530730332 | chr1:195855583-195855584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs66479711 | chr1:195855600-195855601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538107835 | chr1:195855656-195855657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530763536 | chr1:195855663-195855664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550515928 | chr1:195855678-195855679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577518660 | chr1:195855780-195855781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113488418 | chr1:195855790-195855791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553441828 | chr1:195855818-195855819 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147443453 | chr1:195855828-195855829 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138194122 | chr1:195855856-195855857 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs193289927 | chr1:195855868-195855869 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1376807 | chr1:195855886-195855887 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs6696885 | chr1:195855900-195855901 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs565444700 | chr1:195855925-195855926 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532537917 | chr1:195855942-195855943 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6659459 | chr1:195855996-195855997 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs559860367 | chr1:195856030-195856031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530187654 | chr1:195856056-195856057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185471785 | chr1:195856064-195856065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71567566 | chr1:195856113-195856114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188845738 | chr1:195856141-195856142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111704972 | chr1:195856143-195856144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs370043993 | chr1:195856147-195856148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149525217 | chr1:195856174-195856175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550046005 | chr1:195856177-195856178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571491109 | chr1:195856195-195856196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2923885 | chr1:195856224-195856225 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs144040238 | chr1:195856264-195856265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192125103 | chr1:195856355-195856356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184213253 | chr1:195856429-195856430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs373367107 | chr1:195856442-195856443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188562381 | chr1:195856465-195856466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs180926394 | chr1:195856495-195856496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565360096 | chr1:195856499-195856500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535910476 | chr1:195856547-195856548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554255689 | chr1:195856551-195856552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10801486 | chr1:195856591-195856592 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs548476102 | chr1:195856623-195856624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559196948 | chr1:195856693-195856694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574683008 | chr1:195856699-195856700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 21062444 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:195855400-195855800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr1:195855400-195855800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr1:195855400-195855800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr1:195855400-195856000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr1:195855400-195856000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr1:195855800-195858200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr1:195858200-195858800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr1:195862800-195864200 | Enhancers | K562 | blood |
9 | chr1:195863000-195863200 | Enhancers | Aorta | Aorta |
10 | chr1:195863200-195864000 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr1:195863200-195864200 | Enhancers | Fetal Heart | heart |
12 | chr1:195863200-195864200 | Enhancers | HMEC | breast |
13 | chr1:195863200-195864400 | Enhancers | Left Ventricle | heart |
14 | chr1:195863400-195864400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
15 | chr1:195863400-195864400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
16 | chr1:195863600-195864000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr1:195863600-195864000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr1:195863600-195864200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr1:195863600-195864200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
20 | chr1:195863800-195864200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr1:195863800-195864200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
22 | chr1:195864200-195866400 | Weak transcription | K562 | blood |
23 | chr1:195864200-195868800 | Weak transcription | HMEC | breast |
24 | chr1:195864400-195868800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
25 | chr1:195864400-195869000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
26 | chr1:195866400-195866600 | Enhancers | K562 | blood |